First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumor
Interventions: DRUG: MSC2363318A|DRUG: MSC2363318A plus Trastuzumab|DRUG: MSC2363318A plus Tamoxifen
Sponsor: EMD Serono